Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Esomeprazole 20mg gastro-resistant capsules
0103050E0AAAFAF
|
Esomeprazole | Esomeprazole | Gastro-Intestinal System | 169,382 |
|
Esomeprazole 40mg gastro-resistant capsules
0103050E0AAAGAG
|
Esomeprazole | Esomeprazole | Gastro-Intestinal System | 129,508 |
|
Esomeprazole 20mg gastro-resistant tablets
0103050E0AAAAAA
|
Esomeprazole | Esomeprazole | Gastro-Intestinal System | 122,764 |
|
Esomeprazole 40mg gastro-resistant tablets
0103050E0AAABAB
|
Esomeprazole | Esomeprazole | Gastro-Intestinal System | 112,667 |
|
Nexium 20mg gastro-resistant tablets (AstraZeneca)
0103050E0BBAAAA
|
Nexium | Esomeprazole | Gastro-Intestinal System | 11,473 |
|
Nexium 40mg gastro-resistant tablets (AstraZeneca)
0103050E0BBABAB
|
Nexium | Esomeprazole | Gastro-Intestinal System | 7,759 |
|
Emozul 20mg gastro-resistant capsules
0103050E0BCAAAF
|
Emozul | Esomeprazole | Gastro-Intestinal System | 3,655 |
|
Esomeprazole 10mg gastro-resistant granules sachets
0103050E0AAAEAE
|
Esomeprazole | Esomeprazole | Gastro-Intestinal System | 3,291 |
|
Emozul 40mg gastro-resistant capsules
0103050E0BCABAG
|
Emozul | Esomeprazole | Gastro-Intestinal System | 3,234 |
|
Nexium 10mg gastro-resistant granules sachets
0103050E0BBADAE
|
Nexium | Esomeprazole | Gastro-Intestinal System | 324 |
|
Ventra 40mg gastro-resistant capsules
0103050E0BDABAG
|
Ventra | Esomeprazole | Gastro-Intestinal System | 197 |
|
Ventra 20mg gastro-resistant capsules
0103050E0BDAAAF
|
Ventra | Esomeprazole | Gastro-Intestinal System | 170 |
|
Nexium Control 20mg gastro-resistant tablets
0103050E0BBAGAA
|
Nexium | Esomeprazole | Gastro-Intestinal System | 132 |
|
Nexium Control 20mg gastro-resistant capsules
0103050E0BBAHAF
|
Nexium | Esomeprazole | Gastro-Intestinal System | 24 |
|
Esomeprazole 40mg powder for solution for injection vials
0103050E0AAACAC
|
Esomeprazole | Esomeprazole | Gastro-Intestinal System | 19 |
|
Esomeprazole 40mg/5ml oral suspension
0103050E0AAADAD
|
Esomeprazole | Esomeprazole | Gastro-Intestinal System | 7 |
|
Guardium acid reflux control 20mg gastro-resistant tablets
0103050E0BEAAAA
|
Guardium | Esomeprazole | Gastro-Intestinal System | No data available |
|
Nexium 20mg gastro-resistant tablets (Arrow)
0103050E0BBAEAA
|
Nexium | Esomeprazole | Gastro-Intestinal System | No data available |
|
Nexium 40mg gastro-resistant tablets (Arrow)
0103050E0BBAFAB
|
Nexium | Esomeprazole | Gastro-Intestinal System | No data available |
|
Nexium I.V 40mg powder for solution for injection vials
0103050E0BBACAC
|
Nexium | Esomeprazole | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.